Published in J Ultrastruct Res on March 01, 1966
The characterization of soluble amyloid prepared in water. J Clin Invest (1968) 6.17
Characterization of C-reactive protein and the complement subcomponent C1t as homologous proteins displaying cyclic pentameric symmetry (pentraxins). Proc Natl Acad Sci U S A (1977) 3.13
A serum component related to nonimmunoglobulin amyloid protein AS, a possible precursor of the fibrils. J Clin Invest (1974) 2.78
High-resolution electron microscopic analysis of the amyloid fibril. J Cell Biol (1967) 2.16
Binding of serum amyloid P-component (SAP) by amyloid fibrils. Clin Exp Immunol (1979) 2.08
Isolation and characterization of C-reactive protein and serum amyloid P component in the rat. Immunology (1982) 1.67
Amyloid P-component is a constituent of normal human glomerular basement membrane. J Exp Med (1980) 1.57
Fibronectin and C4-binding protein are selectively bound by aggregated amyloid P component. J Exp Med (1981) 1.53
A symmetrical, extracellular fibril. J Cell Biol (1969) 1.32
Primary structure of human C-reactive protein. Proc Natl Acad Sci U S A (1977) 1.17
Ultrastructure of Reichert's membrane, a multilayered basement membrane in the parietal wall of the rat yolk sac. J Cell Biol (1983) 1.06
Amyloid P-component in mice injected with casein: identification in amyloid deposits and in the cytoplasm of hepatocytes. Immunology (1980) 0.98
Immunogenicity of amyloid. Immunology (1971) 0.96
Hamster female protein. A divergent acute phase protein in male and female Syrian hamsters. J Exp Med (1983) 0.94
The isolation and identification of the P-component of normal human plasma proteins. Biochem J (1974) 0.93
Morphology of chronic collagen resorption. A study on the late stages of schistosomal granuloma involution. Am J Pathol (1988) 0.91
Individual antigenic specificity and cross-reactions among amyloid preparations from different individuals. Clin Exp Immunol (1972) 0.90
Amyloidosis and female protein in the Syrian hamster. Concurrent regulation by sex hormones. J Exp Med (1990) 0.90
Reconstitution of amyloid fibrils from alkaline extracts. J Cell Biol (1967) 0.86
Hamster female protein, a sex-limited pentraxin, is a constituent of Syrian hamster amyloid. J Clin Invest (1985) 0.80
The relationship of a serum protein, C1t, to a common nonfibrillar constituent of amyloid (P component) as revealed by immunohistochemical studies. Am J Pathol (1977) 0.78
Comparison of some murine and human amyloid preparations. Br J Exp Pathol (1973) 0.75
Some clinical observations on the nature of amyloid. Trans Am Clin Climatol Assoc (1970) 0.75
Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun (1984) 20.07
Amyloid deposits and amyloidosis. The beta-fibrilloses (first of two parts). N Engl J Med (1980) 9.38
Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem Biophys Res Commun (1984) 8.14
Scrapie prions aggregate to form amyloid-like birefringent rods. Cell (1983) 7.92
X-ray diffraction studies on amyloid filaments. J Histochem Cytochem (1968) 4.54
Amyloid fibril proteins: proof of homology with immunoglobulin light chains by sequence analyses. Science (1971) 4.27
Amyloid deposits and amyloidosis: the beta-fibrilloses (second of two parts). N Engl J Med (1980) 3.95
Neuritic plaques and cerebrovascular amyloid in Alzheimer disease are antigenically related. Proc Natl Acad Sci U S A (1985) 3.54
Creation of "amyloid" fibrils from Bence Jones proteins in vitro. Science (1971) 3.14
Interactions of the complement system with the surface and endotoxic lipopolysaccharide of Veillonella alcalescens. J Exp Med (1967) 2.87
Beta-pleated sheet fibrils. A comparison of native amyloid with synthetic protein fibrils. J Histochem Cytochem (1974) 2.69
Degradation of collagen by a human granulocyte collagenolytic system. J Clin Invest (1968) 2.62
Electron microscopic localization of endotoxic lipopolysaccharide in gram-negative organisms. Ann N Y Acad Sci (1966) 2.61
Differences between vascular and plaque core amyloid in Alzheimer's disease. J Neurochem (1988) 2.24
Amyloidosis: its nature and pathogenesis. Semin Hematol (1973) 2.21
Properties of dissociatively extracted fetal tooth matrix proteins. I. Principal molecular species in developing bovine enamel. J Biol Chem (1980) 2.18
A new dipeptide naphthylamidase hydrolyzing glycyl-prolyl-beta-naphthylamide. Histochemie (1966) 1.98
Amyloid, amyloidosis, and amyloidogenesis. Int Rev Exp Pathol (1976) 1.97
Lesions in Escherichia coli membranes after action of antibody and complement. J Bacteriol (1966) 1.94
Amino acid sequence of an amyloid fibril protein of unknown origin. J Biol Chem (1972) 1.90
Amyloid fibril protein AA: purification and properties of the antigenically related serum component as determined by solid phase radioimmunoassay. J Immunol (1976) 1.89
Isolation of a low-molecular-weight serum component antigenically related to an amyloid fibril protein of unknown origin. Proc Natl Acad Sci U S A (1975) 1.84
The immunoglobulin origin of amyloid. Am J Med (1972) 1.64
Ultrastructure of Treponema microdentium and Borrelia vincentii. J Bacteriol (1964) 1.62
Morphology and distribution of plaque and related deposits in the brains of Alzheimer's disease and control cases. An immunohistochemical study using amyloid beta-protein antibody. Lab Invest (1989) 1.56
Congophilic angiopathy in the pathogenesis of Alzheimer's degeneration. Ann Pathol (1981) 1.51
Structural identity of Bence Jones and amyloid fibril proteins in a patient with plasma cell dyscrasia and amyloidosis. J Clin Invest (1973) 1.51
The amyloid deposits in Alzheimer's disease: their nature and pathogenesis. Appl Pathol (1984) 1.49
Ultrastructure of the human carotid body. A perspective on the mode of chemoreception. Circulation (1968) 1.48
Human amyloid protein: chemical variability and homogeneity. J Histochem Cytochem (1971) 1.45
Re-examination of ex-boxers' brains using immunohistochemistry with antibodies to amyloid beta-protein and tau protein. Acta Neuropathol (1991) 1.43
Immunochemical cross-reactions of human amyloid proteins with human immunoglobulin light polypeptide chains. J Immunol (1972) 1.39
A hog kidney aminopeptidase liberating N-terminal dipeptides. Partial purification and characteristics. Acta Chem Scand (1968) 1.38
Hydrazine-deproteinated bone mineral. Physical and chemical properties. Calcif Tissue Res (1973) 1.37
Histology and ultrastructure of carotid body paragangliomas. Comparison with the normal gland. Cancer (1967) 1.36
Primary localized amyloidosis of the genitourinary tract: immunohistochemical study on eleven cases. Lab Invest (1981) 1.34
The relation of the properties of Congo red-stained amyloid fibrils to the -conformation. J Histochem Cytochem (1972) 1.32
Interactions of the complement system with endotoxins from a Salmonella minnesota mutant deficient in O-polysaccharide and heptose. J Immunol (1968) 1.27
Murine amyloidosis: immunologic characterization of amyloid fibril protein. J Immunol (1971) 1.25
Congophilic microangiopathy in the pathogenesis of Alzheimer's syndrome (presenile dementia). Med Hypotheses (1979) 1.24
Physical and chemical properties of amyloid fibers. II. Isolation of a unique protein constituting the major component from human splenic amyloid fibril concentrates. J Histochem Cytochem (1969) 1.21
An amyloid fibril protein of unknown origin: partial amino-acid sequence analysis. Biochem Biophys Res Commun (1972) 1.21
Primary amyloidosis. Ann Intern Med (1968) 1.20
Murine amyloid fibril protein: isolation, purification and characterization. J Histochem Cytochem (1971) 1.17
Amyloid A: amphipathic helixes and lipid binding. Biochemistry (1976) 1.15
Evidence of amyloid beta-protein immunoreactive early plaque lesions in Down's syndrome brains. Lab Invest (1989) 1.13
Infrared spectroscopy of human amyloid fibrils and immunoglobulin proteins. Biopolymers (1972) 1.13
The purification of amyloid fibril proteins. Prep Biochem (1972) 1.12
Purification of aminopeptidase A in human serum and degradation of angiotensin II by the purified enzyme. Biochim Biophys Acta (1970) 1.12
Immunoglobulin origin of localized nodular pulmonary amyloidosis. Res Exp Med (Berl) (1972) 1.11
Identification and classification of amyloid in formalin-fixed, paraffin-embedded tissue sections by the unlabeled immunoperoxidase method. Lab Invest (1980) 1.11
An electron microscopic study of the formation of amorphous calcium phosphate and its transformation to crystalline apatite. Calcif Tissue Res (1973) 1.10
On causative theories in Alzheimer's disease. Hum Pathol (1985) 1.09
Characterization of aminopeptidase B: substrate specificity and affector studies. Arch Biochem Biophys (1966) 1.08
An amyloid protein: the amino-terminal variable fragment of an immunoglobulin light chain. Biochem Biophys Res Commun (1970) 1.08
Amyloid. VI. A comparison of two morphologic components of human amyloid deposits. J Histochem Cytochem (1968) 1.08
Purification of a mammalian peptidase selective for N-terminal arginine and lysine residues: aminopeptidase B. Arch Biochem Biophys (1966) 1.08
Immunochemical studies on the nature of the serum component (SAA) related to secondary amyloidosis. J Lab Clin Med (1977) 1.07
Amyloid. IX. Further kinetic studies on experimental murine amyloidosis. Int Arch Allergy Appl Immunol (1970) 1.06
Amyloid. 3. A method for rapid induction of amyloidosis in mice. Int Arch Allergy Appl Immunol (1968) 1.05
Quantitation of tissue-bound renal aminopeptidase by a microdensitometric technique. J Histochem Cytochem (1966) 1.04
The enzymatic hydrolysis of amino acid beta-naphthylamides. II. Partial purification and properties of a particle-bound cobalt-activated rat kidney aminopeptidase. J Histochem Cytochem (1966) 1.04
Immunohistochemical evidence for the derivation of a peptide ligand from the amyloid beta-protein precursor of Alzheimer disease. Proc Natl Acad Sci U S A (1988) 1.03
Amyloid. IV. Is human amyloid immunogenic? Int Arch Allergy Appl Immunol (1968) 1.01
Amyloid. 8. On strain variability in experimental murine amyloidosis. Proc Soc Exp Biol Med (1969) 1.00
Cestode calcareous corpuscles: phosphate relationships, crystallization patterns, and variations in size and shape. Exp Parasitol (1969) 0.98
Conformational flexibility of the serum amyloid precursor SAA. Br J Exp Pathol (1976) 0.97
Cerebrovascular amyloid in scrapie-affected sheep reacts with antibodies to prion protein. Neurosci Lett (1988) 0.97
Early senile plaques in Alzheimer's disease demonstrated by histochemistry, immunocytochemistry, and electron microscopy. Hum Pathol (1990) 0.97
Chemical evidence for lambda-type amyloid fibril proteins. J Immunol (1972) 0.96
Comparative studies on the chemistry of collagen utilizing cyanogen bromide cleavage. Brookhaven Symp Biol (1968) 0.95
Immunogold labeling of cerebrovascular and neuritic plaque amyloid fibrils in Alzheimer's disease with an anti-beta protein monoclonal antibody. Lab Invest (1987) 0.93
The bases of the staining of amyloid fibers: their physico-chemical nature and the mechanism of their dye-substrate interaction. Prog Histochem Cytochem (1981) 0.92
Serum aminopeptidases, "angiotensinase," and hypertension. I. Degradation of angiotensin II by human serum. Biochem Pharmacol (1965) 0.92
A peptidase (aminopeptidase B) from cat and guinea pig liver selective for N-terminal arginine and lysine residues. I. Purification and substrate specificity. Acta Chem Scand (1966) 0.92
beta-Amyloid protein immunoreactivity in muscle of patients with inclusion-body myositis. Lancet (1992) 0.91
A study of the morphology and distribution of amyloid beta protein immunoreactive plaque and related lesions in the brains of Alzheimer's disease and adult Down's syndrome. Prog Clin Biol Res (1989) 0.91
The pathogenetic and therapeutic implications of the discovery of the immunoglobulin origin of amyloid fibrils. Hum Pathol (1972) 0.90
Alzheimer's disease. The commonest form of amyloidosis. Arch Pathol Lab Med (1983) 0.90
A pyrrolidonecarboxylate peptidase from the particulate fraction of Klebsiella cloacae. Purification of the stable enzyme and its use in releasing the NH2 terminus from pyrrolidonecarboxylyl peptides and proteins. J Biol Chem (1974) 0.90
Organic matrix of cestode calcareous corpuscles. Exp Parasitol (1970) 0.90
Cathepsin C activity as related to some histochemical substrates. Histochemie (1965) 0.90
Factor X deficiency and systemic amyloidosis. N Engl J Med (1977) 0.89
Amyloidosis. Its role in Alzheimer's disease and other diseases. Ann Pathol (1981) 0.89
A method for electron microscopic localization of aryl-sulphatase. Ann Med Exp Biol Fenn (1965) 0.89
Purification and reconstitution of the periodic fibril and unit structure of human amyloid. Science (1966) 0.89
Social interaction and wounding in the genesis of "spontaneous" murine amyloidosis. Am J Pathol (1972) 0.87
A peptidase (aminopeptidase B) from cat and guinea pig liver selective for N-terminal arginine and lysine residues. II. Modifier characteristics and kinetic studies. Acta Chem Scand (1966) 0.87
Immunoglobulin D myeloma and amyloidosis: immunochemical and structural studies of Bence Jones and amyloid fibrillar proteins. Blood (1975) 0.86
Serum aminopeptidases, "angiotensinase," and hypertension. II. Amino acid beta-napthylamide hydrolysis by normal and hypertensive serum. Biochem Pharmacol (1965) 0.86
Observations on calcareous corpuscles of larval Echinococcus granulosus of various geographic origins. Proc Soc Exp Biol Med (1965) 0.86
Nature of amyloid deposits in hypernephroma. Immunocytochemical studies in 2 cases associated with amyloid polyneuropathy. Am J Pathol (1984) 0.85
19th Annual Meeting of the Histochemical Society, New Orleans, April 8-9, 1968. Symposium on critical evaluation of morphologic histochemical techniques for demonstrating enzymes. Evaluation of the specificity of enzyme histochemical reactions. J Histochem Cytochem (1968) 0.84